nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—ABCB1—lung cancer	0.165	1	CbGaD
Bromocriptine—ABCB1—Topotecan—lung cancer	0.0302	0.0791	CbGbCtD
Bromocriptine—ABCB1—Gefitinib—lung cancer	0.0276	0.0723	CbGbCtD
Bromocriptine—ABCB1—Vinorelbine—lung cancer	0.0213	0.0557	CbGbCtD
Bromocriptine—CYP1A2—Erlotinib—lung cancer	0.0187	0.0489	CbGbCtD
Bromocriptine—CYP3A4—Topotecan—lung cancer	0.0181	0.0474	CbGbCtD
Bromocriptine—ABCB1—Crizotinib—lung cancer	0.0169	0.0443	CbGbCtD
Bromocriptine—CYP3A4—Gefitinib—lung cancer	0.0165	0.0433	CbGbCtD
Bromocriptine—ABCB1—Gemcitabine—lung cancer	0.0165	0.0433	CbGbCtD
Bromocriptine—ABCB1—Erlotinib—lung cancer	0.0163	0.0428	CbGbCtD
Bromocriptine—CYP3A4—Teniposide—lung cancer	0.016	0.042	CbGbCtD
Bromocriptine—ABCB1—Paclitaxel—lung cancer	0.0149	0.0392	CbGbCtD
Bromocriptine—ABCB1—Irinotecan—lung cancer	0.0147	0.0386	CbGbCtD
Bromocriptine—CYP1A2—Etoposide—lung cancer	0.0135	0.0354	CbGbCtD
Bromocriptine—ABCB1—Vinblastine—lung cancer	0.0131	0.0343	CbGbCtD
Bromocriptine—CYP3A4—Vinorelbine—lung cancer	0.0127	0.0334	CbGbCtD
Bromocriptine—ABCB1—Cisplatin—lung cancer	0.012	0.0315	CbGbCtD
Bromocriptine—ABCB1—Etoposide—lung cancer	0.0118	0.0309	CbGbCtD
Bromocriptine—ABCB1—Docetaxel—lung cancer	0.0108	0.0283	CbGbCtD
Bromocriptine—CYP3A4—Crizotinib—lung cancer	0.0101	0.0266	CbGbCtD
Bromocriptine—CYP3A4—Erlotinib—lung cancer	0.00978	0.0256	CbGbCtD
Bromocriptine—CYP3A4—Paclitaxel—lung cancer	0.00896	0.0235	CbGbCtD
Bromocriptine—CYP3A4—Irinotecan—lung cancer	0.00883	0.0231	CbGbCtD
Bromocriptine—HTR2A—phrenic nerve—lung cancer	0.00822	0.254	CbGeAlD
Bromocriptine—ABCB1—Doxorubicin—lung cancer	0.00806	0.0211	CbGbCtD
Bromocriptine—CYP3A4—Vinblastine—lung cancer	0.00785	0.0206	CbGbCtD
Bromocriptine—ABCB1—Methotrexate—lung cancer	0.0078	0.0204	CbGbCtD
Bromocriptine—CYP3A4—Etoposide—lung cancer	0.00708	0.0185	CbGbCtD
Bromocriptine—CYP3A4—Docetaxel—lung cancer	0.00647	0.017	CbGbCtD
Bromocriptine—CYP3A4—Doxorubicin—lung cancer	0.00483	0.0126	CbGbCtD
Bromocriptine—HTR7—pulmonary artery—lung cancer	0.00478	0.148	CbGeAlD
Bromocriptine—HTR2A—pulmonary artery—lung cancer	0.00298	0.0922	CbGeAlD
Bromocriptine—ADRA1D—epithelium—lung cancer	0.00113	0.0349	CbGeAlD
Bromocriptine—ADRB1—bronchus—lung cancer	0.000808	0.025	CbGeAlD
Bromocriptine—HTR7—respiratory system—lung cancer	0.000805	0.0249	CbGeAlD
Bromocriptine—DRD2—respiratory system—lung cancer	0.000761	0.0235	CbGeAlD
Bromocriptine—ADRB1—cardiac atrium—lung cancer	0.000681	0.0211	CbGeAlD
Bromocriptine—HTR7—epithelium—lung cancer	0.000672	0.0208	CbGeAlD
Bromocriptine—ADRA1A—epithelium—lung cancer	0.000649	0.0201	CbGeAlD
Bromocriptine—CYP1A2—respiratory system—lung cancer	0.000642	0.0198	CbGeAlD
Bromocriptine—ADRA2C—bronchus—lung cancer	0.000609	0.0188	CbGeAlD
Bromocriptine—HTR7—trachea—lung cancer	0.000595	0.0184	CbGeAlD
Bromocriptine—ADRA2C—trachea—lung cancer	0.000547	0.0169	CbGeAlD
Bromocriptine—ADRB1—lung—lung cancer	0.000521	0.0161	CbGeAlD
Bromocriptine—ADRA2C—cardiac atrium—lung cancer	0.000513	0.0159	CbGeAlD
Bromocriptine—HTR2A—respiratory system—lung cancer	0.000502	0.0155	CbGeAlD
Bromocriptine—HTR2B—lung—lung cancer	0.000499	0.0154	CbGeAlD
Bromocriptine—ADRA2A—bronchus—lung cancer	0.000486	0.015	CbGeAlD
Bromocriptine—Dihydroergotamine—ABCB1—lung cancer	0.000456	0.412	CrCbGaD
Bromocriptine—ADRA2A—trachea—lung cancer	0.000436	0.0135	CbGeAlD
Bromocriptine—HTR7—lung—lung cancer	0.000427	0.0132	CbGeAlD
Bromocriptine—HTR2A—epithelium—lung cancer	0.000419	0.013	CbGeAlD
Bromocriptine—Ergonovine—ABCB1—lung cancer	0.000417	0.377	CrCbGaD
Bromocriptine—ADRA2A—cardiac atrium—lung cancer	0.00041	0.0127	CbGeAlD
Bromocriptine—DRD2—lung—lung cancer	0.000404	0.0125	CbGeAlD
Bromocriptine—ADRA2C—lung—lung cancer	0.000393	0.0121	CbGeAlD
Bromocriptine—HTR2A—trachea—lung cancer	0.000371	0.0115	CbGeAlD
Bromocriptine—HTR2B—lymph node—lung cancer	0.000341	0.0106	CbGeAlD
Bromocriptine—CYP1A2—lung—lung cancer	0.000341	0.0105	CbGeAlD
Bromocriptine—ABCB1—respiratory system—lung cancer	0.000329	0.0102	CbGeAlD
Bromocriptine—ADRA2A—lung—lung cancer	0.000313	0.00969	CbGeAlD
Bromocriptine—ABCB1—epithelium—lung cancer	0.000275	0.0085	CbGeAlD
Bromocriptine—ADRA2C—lymph node—lung cancer	0.000269	0.0083	CbGeAlD
Bromocriptine—HTR2A—lung—lung cancer	0.000266	0.00824	CbGeAlD
Bromocriptine—ABCB1—trachea—lung cancer	0.000243	0.00751	CbGeAlD
Bromocriptine—Ergotamine—ABCB1—lung cancer	0.000235	0.212	CrCbGaD
Bromocriptine—ADRA2A—lymph node—lung cancer	0.000214	0.00663	CbGeAlD
Bromocriptine—ABCB1—bone marrow—lung cancer	0.000193	0.00596	CbGeAlD
Bromocriptine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000177	0.000663	CcSEcCtD
Bromocriptine—Abdominal discomfort—Methotrexate—lung cancer	0.000177	0.000662	CcSEcCtD
Bromocriptine—Fatigue—Gemcitabine—lung cancer	0.000177	0.000662	CcSEcCtD
Bromocriptine—Confusional state—Etoposide—lung cancer	0.000177	0.000661	CcSEcCtD
Bromocriptine—Constipation—Gemcitabine—lung cancer	0.000176	0.000657	CcSEcCtD
Bromocriptine—Nausea—Erlotinib—lung cancer	0.000176	0.000657	CcSEcCtD
Bromocriptine—Dry mouth—Paclitaxel—lung cancer	0.000176	0.000656	CcSEcCtD
Bromocriptine—Diarrhoea—Vinorelbine—lung cancer	0.000175	0.000654	CcSEcCtD
Bromocriptine—Dysgeusia—Docetaxel—lung cancer	0.000175	0.000654	CcSEcCtD
Bromocriptine—ABCB1—lung—lung cancer	0.000175	0.0054	CbGeAlD
Bromocriptine—Infection—Etoposide—lung cancer	0.000174	0.000652	CcSEcCtD
Bromocriptine—Ataxia—Doxorubicin—lung cancer	0.000174	0.000651	CcSEcCtD
Bromocriptine—Feeling abnormal—Irinotecan—lung cancer	0.000174	0.00065	CcSEcCtD
Bromocriptine—Confusional state—Paclitaxel—lung cancer	0.000173	0.000648	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Irinotecan—lung cancer	0.000172	0.000645	CcSEcCtD
Bromocriptine—Oedema—Paclitaxel—lung cancer	0.000172	0.000643	CcSEcCtD
Bromocriptine—Paraesthesia—Cisplatin—lung cancer	0.000172	0.000643	CcSEcCtD
Bromocriptine—Muscle spasms—Docetaxel—lung cancer	0.000172	0.000642	CcSEcCtD
Bromocriptine—Tachycardia—Etoposide—lung cancer	0.000171	0.00064	CcSEcCtD
Bromocriptine—Infection—Paclitaxel—lung cancer	0.000171	0.000639	CcSEcCtD
Bromocriptine—Dyspnoea—Cisplatin—lung cancer	0.000171	0.000638	CcSEcCtD
Bromocriptine—Skin disorder—Etoposide—lung cancer	0.00017	0.000637	CcSEcCtD
Bromocriptine—Feeling abnormal—Gemcitabine—lung cancer	0.000169	0.000633	CcSEcCtD
Bromocriptine—Shock—Paclitaxel—lung cancer	0.000169	0.000633	CcSEcCtD
Bromocriptine—Dizziness—Vinorelbine—lung cancer	0.000169	0.000632	CcSEcCtD
Bromocriptine—Abdominal pain upper—Doxorubicin—lung cancer	0.000169	0.000632	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000169	0.000632	CcSEcCtD
Bromocriptine—Nervous system disorder—Paclitaxel—lung cancer	0.000169	0.000631	CcSEcCtD
Bromocriptine—Tachycardia—Paclitaxel—lung cancer	0.000168	0.000628	CcSEcCtD
Bromocriptine—Anorexia—Etoposide—lung cancer	0.000167	0.000625	CcSEcCtD
Bromocriptine—Skin disorder—Paclitaxel—lung cancer	0.000167	0.000625	CcSEcCtD
Bromocriptine—Body temperature increased—Irinotecan—lung cancer	0.000167	0.000623	CcSEcCtD
Bromocriptine—Abdominal pain—Irinotecan—lung cancer	0.000167	0.000623	CcSEcCtD
Bromocriptine—Decreased appetite—Cisplatin—lung cancer	0.000166	0.000622	CcSEcCtD
Bromocriptine—Nasopharyngitis—Doxorubicin—lung cancer	0.000166	0.000619	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000165	0.000618	CcSEcCtD
Bromocriptine—Drowsiness—Methotrexate—lung cancer	0.000165	0.000616	CcSEcCtD
Bromocriptine—Anorexia—Paclitaxel—lung cancer	0.000164	0.000613	CcSEcCtD
Bromocriptine—Hypotension—Etoposide—lung cancer	0.000164	0.000613	CcSEcCtD
Bromocriptine—Vomiting—Vinorelbine—lung cancer	0.000163	0.000608	CcSEcCtD
Bromocriptine—Body temperature increased—Gemcitabine—lung cancer	0.000162	0.000607	CcSEcCtD
Bromocriptine—Rash—Vinorelbine—lung cancer	0.000161	0.000603	CcSEcCtD
Bromocriptine—Dermatitis—Vinorelbine—lung cancer	0.000161	0.000602	CcSEcCtD
Bromocriptine—Hypotension—Paclitaxel—lung cancer	0.000161	0.000601	CcSEcCtD
Bromocriptine—Headache—Vinorelbine—lung cancer	0.00016	0.000599	CcSEcCtD
Bromocriptine—Syncope—Docetaxel—lung cancer	0.00016	0.000599	CcSEcCtD
Bromocriptine—Influenza—Doxorubicin—lung cancer	0.00016	0.000598	CcSEcCtD
Bromocriptine—Dysphagia—Doxorubicin—lung cancer	0.00016	0.000598	CcSEcCtD
Bromocriptine—Feeling abnormal—Cisplatin—lung cancer	0.000158	0.00059	CcSEcCtD
Bromocriptine—Paraesthesia—Etoposide—lung cancer	0.000158	0.000589	CcSEcCtD
Bromocriptine—Loss of consciousness—Docetaxel—lung cancer	0.000157	0.000587	CcSEcCtD
Bromocriptine—Dyspnoea—Etoposide—lung cancer	0.000156	0.000585	CcSEcCtD
Bromocriptine—Somnolence—Etoposide—lung cancer	0.000156	0.000583	CcSEcCtD
Bromocriptine—Insomnia—Paclitaxel—lung cancer	0.000156	0.000582	CcSEcCtD
Bromocriptine—Convulsion—Docetaxel—lung cancer	0.000155	0.000579	CcSEcCtD
Bromocriptine—Paraesthesia—Paclitaxel—lung cancer	0.000154	0.000577	CcSEcCtD
Bromocriptine—Hypertension—Docetaxel—lung cancer	0.000154	0.000577	CcSEcCtD
Bromocriptine—Dyspnoea—Paclitaxel—lung cancer	0.000153	0.000573	CcSEcCtD
Bromocriptine—Somnolence—Paclitaxel—lung cancer	0.000153	0.000572	CcSEcCtD
Bromocriptine—Decreased appetite—Etoposide—lung cancer	0.000153	0.00057	CcSEcCtD
Bromocriptine—Nausea—Vinorelbine—lung cancer	0.000152	0.000568	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Etoposide—lung cancer	0.000151	0.000566	CcSEcCtD
Bromocriptine—Dyspepsia—Paclitaxel—lung cancer	0.000151	0.000566	CcSEcCtD
Bromocriptine—Body temperature increased—Cisplatin—lung cancer	0.000151	0.000566	CcSEcCtD
Bromocriptine—Asthenia—Irinotecan—lung cancer	0.000151	0.000566	CcSEcCtD
Bromocriptine—Fatigue—Etoposide—lung cancer	0.000151	0.000565	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000151	0.000565	CcSEcCtD
Bromocriptine—Constipation—Etoposide—lung cancer	0.00015	0.000561	CcSEcCtD
Bromocriptine—Decreased appetite—Paclitaxel—lung cancer	0.00015	0.000559	CcSEcCtD
Bromocriptine—Dry mouth—Docetaxel—lung cancer	0.000149	0.000556	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000149	0.000555	CcSEcCtD
Bromocriptine—Fatigue—Paclitaxel—lung cancer	0.000148	0.000554	CcSEcCtD
Bromocriptine—Pollakiuria—Doxorubicin—lung cancer	0.000148	0.000553	CcSEcCtD
Bromocriptine—Asthenia—Gemcitabine—lung cancer	0.000147	0.000551	CcSEcCtD
Bromocriptine—Constipation—Paclitaxel—lung cancer	0.000147	0.00055	CcSEcCtD
Bromocriptine—Confusional state—Docetaxel—lung cancer	0.000147	0.00055	CcSEcCtD
Bromocriptine—Oedema—Docetaxel—lung cancer	0.000146	0.000545	CcSEcCtD
Bromocriptine—Infection—Docetaxel—lung cancer	0.000145	0.000541	CcSEcCtD
Bromocriptine—Feeling abnormal—Etoposide—lung cancer	0.000145	0.00054	CcSEcCtD
Bromocriptine—Diarrhoea—Irinotecan—lung cancer	0.000144	0.000539	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Etoposide—lung cancer	0.000143	0.000536	CcSEcCtD
Bromocriptine—Shock—Docetaxel—lung cancer	0.000143	0.000536	CcSEcCtD
Bromocriptine—Nervous system disorder—Docetaxel—lung cancer	0.000143	0.000535	CcSEcCtD
Bromocriptine—Drowsiness—Doxorubicin—lung cancer	0.000143	0.000533	CcSEcCtD
Bromocriptine—Visual impairment—Methotrexate—lung cancer	0.000143	0.000533	CcSEcCtD
Bromocriptine—Tachycardia—Docetaxel—lung cancer	0.000142	0.000532	CcSEcCtD
Bromocriptine—Feeling abnormal—Paclitaxel—lung cancer	0.000142	0.00053	CcSEcCtD
Bromocriptine—Skin disorder—Docetaxel—lung cancer	0.000142	0.000529	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000141	0.000526	CcSEcCtD
Bromocriptine—Diarrhoea—Gemcitabine—lung cancer	0.000141	0.000525	CcSEcCtD
Bromocriptine—Dizziness—Irinotecan—lung cancer	0.000139	0.000521	CcSEcCtD
Bromocriptine—Urticaria—Etoposide—lung cancer	0.000139	0.000521	CcSEcCtD
Bromocriptine—Anorexia—Docetaxel—lung cancer	0.000139	0.00052	CcSEcCtD
Bromocriptine—Body temperature increased—Etoposide—lung cancer	0.000139	0.000518	CcSEcCtD
Bromocriptine—Abdominal pain—Etoposide—lung cancer	0.000139	0.000518	CcSEcCtD
Bromocriptine—Eye disorder—Methotrexate—lung cancer	0.000138	0.000517	CcSEcCtD
Bromocriptine—Tinnitus—Methotrexate—lung cancer	0.000138	0.000516	CcSEcCtD
Bromocriptine—Asthenia—Cisplatin—lung cancer	0.000137	0.000514	CcSEcCtD
Bromocriptine—Cardiac disorder—Methotrexate—lung cancer	0.000137	0.000513	CcSEcCtD
Bromocriptine—Urticaria—Paclitaxel—lung cancer	0.000137	0.000511	CcSEcCtD
Bromocriptine—Hypotension—Docetaxel—lung cancer	0.000136	0.000509	CcSEcCtD
Bromocriptine—Body temperature increased—Paclitaxel—lung cancer	0.000136	0.000508	CcSEcCtD
Bromocriptine—Abdominal pain—Paclitaxel—lung cancer	0.000136	0.000508	CcSEcCtD
Bromocriptine—Angiopathy—Methotrexate—lung cancer	0.000134	0.000502	CcSEcCtD
Bromocriptine—Vomiting—Irinotecan—lung cancer	0.000134	0.000501	CcSEcCtD
Bromocriptine—Sinusitis—Doxorubicin—lung cancer	0.000134	0.0005	CcSEcCtD
Bromocriptine—Mediastinal disorder—Methotrexate—lung cancer	0.000133	0.000498	CcSEcCtD
Bromocriptine—Rash—Irinotecan—lung cancer	0.000133	0.000497	CcSEcCtD
Bromocriptine—Dermatitis—Irinotecan—lung cancer	0.000133	0.000497	CcSEcCtD
Bromocriptine—Headache—Irinotecan—lung cancer	0.000132	0.000494	CcSEcCtD
Bromocriptine—Insomnia—Docetaxel—lung cancer	0.000132	0.000493	CcSEcCtD
Bromocriptine—Diarrhoea—Cisplatin—lung cancer	0.000131	0.00049	CcSEcCtD
Bromocriptine—Paraesthesia—Docetaxel—lung cancer	0.000131	0.000489	CcSEcCtD
Bromocriptine—Alopecia—Methotrexate—lung cancer	0.000131	0.000489	CcSEcCtD
Bromocriptine—Vomiting—Gemcitabine—lung cancer	0.000131	0.000488	CcSEcCtD
Bromocriptine—Bradycardia—Doxorubicin—lung cancer	0.00013	0.000487	CcSEcCtD
Bromocriptine—Dyspnoea—Docetaxel—lung cancer	0.00013	0.000486	CcSEcCtD
Bromocriptine—Somnolence—Docetaxel—lung cancer	0.00013	0.000485	CcSEcCtD
Bromocriptine—Mental disorder—Methotrexate—lung cancer	0.00013	0.000484	CcSEcCtD
Bromocriptine—Rash—Gemcitabine—lung cancer	0.00013	0.000484	CcSEcCtD
Bromocriptine—Dermatitis—Gemcitabine—lung cancer	0.000129	0.000484	CcSEcCtD
Bromocriptine—Headache—Gemcitabine—lung cancer	0.000129	0.000481	CcSEcCtD
Bromocriptine—Rhinitis—Doxorubicin—lung cancer	0.000128	0.00048	CcSEcCtD
Bromocriptine—Dyspepsia—Docetaxel—lung cancer	0.000128	0.00048	CcSEcCtD
Bromocriptine—Hypoaesthesia—Doxorubicin—lung cancer	0.000127	0.000476	CcSEcCtD
Bromocriptine—Decreased appetite—Docetaxel—lung cancer	0.000127	0.000474	CcSEcCtD
Bromocriptine—Oedema peripheral—Doxorubicin—lung cancer	0.000126	0.000472	CcSEcCtD
Bromocriptine—Dysgeusia—Methotrexate—lung cancer	0.000126	0.000471	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000126	0.000471	CcSEcCtD
Bromocriptine—Asthenia—Etoposide—lung cancer	0.000126	0.000471	CcSEcCtD
Bromocriptine—Connective tissue disorder—Doxorubicin—lung cancer	0.000126	0.00047	CcSEcCtD
Bromocriptine—Fatigue—Docetaxel—lung cancer	0.000126	0.00047	CcSEcCtD
Bromocriptine—Nausea—Irinotecan—lung cancer	0.000125	0.000468	CcSEcCtD
Bromocriptine—Constipation—Docetaxel—lung cancer	0.000125	0.000466	CcSEcCtD
Bromocriptine—Visual impairment—Doxorubicin—lung cancer	0.000123	0.000461	CcSEcCtD
Bromocriptine—Asthenia—Paclitaxel—lung cancer	0.000123	0.000461	CcSEcCtD
Bromocriptine—Nausea—Gemcitabine—lung cancer	0.000122	0.000456	CcSEcCtD
Bromocriptine—Vomiting—Cisplatin—lung cancer	0.000122	0.000455	CcSEcCtD
Bromocriptine—Vision blurred—Methotrexate—lung cancer	0.000121	0.000454	CcSEcCtD
Bromocriptine—Rash—Cisplatin—lung cancer	0.000121	0.000451	CcSEcCtD
Bromocriptine—Dermatitis—Cisplatin—lung cancer	0.000121	0.000451	CcSEcCtD
Bromocriptine—Feeling abnormal—Docetaxel—lung cancer	0.00012	0.000449	CcSEcCtD
Bromocriptine—Diarrhoea—Etoposide—lung cancer	0.00012	0.000449	CcSEcCtD
Bromocriptine—Eye disorder—Doxorubicin—lung cancer	0.00012	0.000447	CcSEcCtD
Bromocriptine—Tinnitus—Doxorubicin—lung cancer	0.000119	0.000446	CcSEcCtD
Bromocriptine—ABCB1—lymph node—lung cancer	0.000119	0.00369	CbGeAlD
Bromocriptine—Gastrointestinal pain—Docetaxel—lung cancer	0.000119	0.000446	CcSEcCtD
Bromocriptine—Cardiac disorder—Doxorubicin—lung cancer	0.000119	0.000444	CcSEcCtD
Bromocriptine—Diarrhoea—Paclitaxel—lung cancer	0.000118	0.00044	CcSEcCtD
Bromocriptine—Angiopathy—Doxorubicin—lung cancer	0.000116	0.000434	CcSEcCtD
Bromocriptine—Dizziness—Etoposide—lung cancer	0.000116	0.000434	CcSEcCtD
Bromocriptine—Vertigo—Methotrexate—lung cancer	0.000116	0.000432	CcSEcCtD
Bromocriptine—Mediastinal disorder—Doxorubicin—lung cancer	0.000115	0.000432	CcSEcCtD
Bromocriptine—Body temperature increased—Docetaxel—lung cancer	0.000115	0.000431	CcSEcCtD
Bromocriptine—Abdominal pain—Docetaxel—lung cancer	0.000115	0.000431	CcSEcCtD
Bromocriptine—Arrhythmia—Doxorubicin—lung cancer	0.000114	0.000428	CcSEcCtD
Bromocriptine—Dizziness—Paclitaxel—lung cancer	0.000114	0.000425	CcSEcCtD
Bromocriptine—Nausea—Cisplatin—lung cancer	0.000114	0.000425	CcSEcCtD
Bromocriptine—Alopecia—Doxorubicin—lung cancer	0.000113	0.000423	CcSEcCtD
Bromocriptine—Mental disorder—Doxorubicin—lung cancer	0.000112	0.000419	CcSEcCtD
Bromocriptine—Convulsion—Methotrexate—lung cancer	0.000112	0.000417	CcSEcCtD
Bromocriptine—Vomiting—Etoposide—lung cancer	0.000112	0.000417	CcSEcCtD
Bromocriptine—Rash—Etoposide—lung cancer	0.000111	0.000414	CcSEcCtD
Bromocriptine—Dermatitis—Etoposide—lung cancer	0.000111	0.000413	CcSEcCtD
Bromocriptine—Headache—Etoposide—lung cancer	0.00011	0.000411	CcSEcCtD
Bromocriptine—Tension—Doxorubicin—lung cancer	0.000109	0.000409	CcSEcCtD
Bromocriptine—Vomiting—Paclitaxel—lung cancer	0.000109	0.000409	CcSEcCtD
Bromocriptine—Dysgeusia—Doxorubicin—lung cancer	0.000109	0.000408	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000109	0.000407	CcSEcCtD
Bromocriptine—Rash—Paclitaxel—lung cancer	0.000108	0.000405	CcSEcCtD
Bromocriptine—Dermatitis—Paclitaxel—lung cancer	0.000108	0.000405	CcSEcCtD
Bromocriptine—Nervousness—Doxorubicin—lung cancer	0.000108	0.000405	CcSEcCtD
Bromocriptine—Headache—Paclitaxel—lung cancer	0.000108	0.000403	CcSEcCtD
Bromocriptine—Muscle spasms—Doxorubicin—lung cancer	0.000107	0.000401	CcSEcCtD
Bromocriptine—Confusional state—Methotrexate—lung cancer	0.000106	0.000396	CcSEcCtD
Bromocriptine—Vision blurred—Doxorubicin—lung cancer	0.000105	0.000393	CcSEcCtD
Bromocriptine—Asthenia—Docetaxel—lung cancer	0.000105	0.000391	CcSEcCtD
Bromocriptine—Infection—Methotrexate—lung cancer	0.000104	0.00039	CcSEcCtD
Bromocriptine—Nausea—Etoposide—lung cancer	0.000104	0.00039	CcSEcCtD
Bromocriptine—Nervous system disorder—Methotrexate—lung cancer	0.000103	0.000385	CcSEcCtD
Bromocriptine—Agitation—Doxorubicin—lung cancer	0.000102	0.000383	CcSEcCtD
Bromocriptine—Nausea—Paclitaxel—lung cancer	0.000102	0.000382	CcSEcCtD
Bromocriptine—Skin disorder—Methotrexate—lung cancer	0.000102	0.000382	CcSEcCtD
Bromocriptine—Vertigo—Doxorubicin—lung cancer	0.0001	0.000374	CcSEcCtD
Bromocriptine—Anorexia—Methotrexate—lung cancer	0.0001	0.000374	CcSEcCtD
Bromocriptine—Syncope—Doxorubicin—lung cancer	0.0001	0.000374	CcSEcCtD
Bromocriptine—Diarrhoea—Docetaxel—lung cancer	9.98e-05	0.000373	CcSEcCtD
Bromocriptine—Hypotension—Methotrexate—lung cancer	9.82e-05	0.000367	CcSEcCtD
Bromocriptine—Loss of consciousness—Doxorubicin—lung cancer	9.8e-05	0.000366	CcSEcCtD
Bromocriptine—Convulsion—Doxorubicin—lung cancer	9.66e-05	0.000361	CcSEcCtD
Bromocriptine—Dizziness—Docetaxel—lung cancer	9.64e-05	0.00036	CcSEcCtD
Bromocriptine—Hypertension—Doxorubicin—lung cancer	9.63e-05	0.00036	CcSEcCtD
Bromocriptine—Insomnia—Methotrexate—lung cancer	9.51e-05	0.000355	CcSEcCtD
Bromocriptine—Anxiety—Doxorubicin—lung cancer	9.46e-05	0.000354	CcSEcCtD
Bromocriptine—Paraesthesia—Methotrexate—lung cancer	9.44e-05	0.000353	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	9.43e-05	0.000352	CcSEcCtD
Bromocriptine—Dyspnoea—Methotrexate—lung cancer	9.37e-05	0.00035	CcSEcCtD
Bromocriptine—Somnolence—Methotrexate—lung cancer	9.34e-05	0.000349	CcSEcCtD
Bromocriptine—Dry mouth—Doxorubicin—lung cancer	9.28e-05	0.000347	CcSEcCtD
Bromocriptine—Vomiting—Docetaxel—lung cancer	9.27e-05	0.000347	CcSEcCtD
Bromocriptine—Dyspepsia—Methotrexate—lung cancer	9.25e-05	0.000346	CcSEcCtD
Bromocriptine—Rash—Docetaxel—lung cancer	9.19e-05	0.000344	CcSEcCtD
Bromocriptine—Dermatitis—Docetaxel—lung cancer	9.19e-05	0.000343	CcSEcCtD
Bromocriptine—Confusional state—Doxorubicin—lung cancer	9.18e-05	0.000343	CcSEcCtD
Bromocriptine—Decreased appetite—Methotrexate—lung cancer	9.14e-05	0.000341	CcSEcCtD
Bromocriptine—Headache—Docetaxel—lung cancer	9.13e-05	0.000341	CcSEcCtD
Bromocriptine—Oedema—Doxorubicin—lung cancer	9.1e-05	0.00034	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Methotrexate—lung cancer	9.07e-05	0.000339	CcSEcCtD
Bromocriptine—Fatigue—Methotrexate—lung cancer	9.06e-05	0.000339	CcSEcCtD
Bromocriptine—Infection—Doxorubicin—lung cancer	9.04e-05	0.000338	CcSEcCtD
Bromocriptine—Shock—Doxorubicin—lung cancer	8.95e-05	0.000335	CcSEcCtD
Bromocriptine—Nervous system disorder—Doxorubicin—lung cancer	8.92e-05	0.000334	CcSEcCtD
Bromocriptine—Tachycardia—Doxorubicin—lung cancer	8.88e-05	0.000332	CcSEcCtD
Bromocriptine—Skin disorder—Doxorubicin—lung cancer	8.84e-05	0.00033	CcSEcCtD
Bromocriptine—Anorexia—Doxorubicin—lung cancer	8.67e-05	0.000324	CcSEcCtD
Bromocriptine—Nausea—Docetaxel—lung cancer	8.66e-05	0.000324	CcSEcCtD
Bromocriptine—Feeling abnormal—Methotrexate—lung cancer	8.66e-05	0.000324	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Methotrexate—lung cancer	8.59e-05	0.000321	CcSEcCtD
Bromocriptine—Hypotension—Doxorubicin—lung cancer	8.5e-05	0.000318	CcSEcCtD
Bromocriptine—Urticaria—Methotrexate—lung cancer	8.35e-05	0.000312	CcSEcCtD
Bromocriptine—Abdominal pain—Methotrexate—lung cancer	8.31e-05	0.000311	CcSEcCtD
Bromocriptine—Body temperature increased—Methotrexate—lung cancer	8.31e-05	0.000311	CcSEcCtD
Bromocriptine—Insomnia—Doxorubicin—lung cancer	8.23e-05	0.000308	CcSEcCtD
Bromocriptine—Paraesthesia—Doxorubicin—lung cancer	8.17e-05	0.000305	CcSEcCtD
Bromocriptine—Dyspnoea—Doxorubicin—lung cancer	8.11e-05	0.000303	CcSEcCtD
Bromocriptine—Somnolence—Doxorubicin—lung cancer	8.09e-05	0.000302	CcSEcCtD
Bromocriptine—Dyspepsia—Doxorubicin—lung cancer	8.01e-05	0.000299	CcSEcCtD
Bromocriptine—Decreased appetite—Doxorubicin—lung cancer	7.91e-05	0.000296	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Doxorubicin—lung cancer	7.86e-05	0.000294	CcSEcCtD
Bromocriptine—Fatigue—Doxorubicin—lung cancer	7.85e-05	0.000293	CcSEcCtD
Bromocriptine—Constipation—Doxorubicin—lung cancer	7.78e-05	0.000291	CcSEcCtD
Bromocriptine—Asthenia—Methotrexate—lung cancer	7.54e-05	0.000282	CcSEcCtD
Bromocriptine—Feeling abnormal—Doxorubicin—lung cancer	7.5e-05	0.00028	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Doxorubicin—lung cancer	7.44e-05	0.000278	CcSEcCtD
Bromocriptine—Urticaria—Doxorubicin—lung cancer	7.23e-05	0.00027	CcSEcCtD
Bromocriptine—Abdominal pain—Doxorubicin—lung cancer	7.19e-05	0.000269	CcSEcCtD
Bromocriptine—Body temperature increased—Doxorubicin—lung cancer	7.19e-05	0.000269	CcSEcCtD
Bromocriptine—Diarrhoea—Methotrexate—lung cancer	7.19e-05	0.000269	CcSEcCtD
Bromocriptine—Dizziness—Methotrexate—lung cancer	6.95e-05	0.00026	CcSEcCtD
Bromocriptine—Vomiting—Methotrexate—lung cancer	6.68e-05	0.00025	CcSEcCtD
Bromocriptine—Rash—Methotrexate—lung cancer	6.63e-05	0.000248	CcSEcCtD
Bromocriptine—Dermatitis—Methotrexate—lung cancer	6.62e-05	0.000247	CcSEcCtD
Bromocriptine—Headache—Methotrexate—lung cancer	6.58e-05	0.000246	CcSEcCtD
Bromocriptine—Asthenia—Doxorubicin—lung cancer	6.53e-05	0.000244	CcSEcCtD
Bromocriptine—Nausea—Methotrexate—lung cancer	6.24e-05	0.000233	CcSEcCtD
Bromocriptine—Diarrhoea—Doxorubicin—lung cancer	6.23e-05	0.000233	CcSEcCtD
Bromocriptine—Dizziness—Doxorubicin—lung cancer	6.02e-05	0.000225	CcSEcCtD
Bromocriptine—Vomiting—Doxorubicin—lung cancer	5.79e-05	0.000216	CcSEcCtD
Bromocriptine—Rash—Doxorubicin—lung cancer	5.74e-05	0.000214	CcSEcCtD
Bromocriptine—Dermatitis—Doxorubicin—lung cancer	5.73e-05	0.000214	CcSEcCtD
Bromocriptine—Headache—Doxorubicin—lung cancer	5.7e-05	0.000213	CcSEcCtD
Bromocriptine—Nausea—Doxorubicin—lung cancer	5.41e-05	0.000202	CcSEcCtD
Bromocriptine—HTR1D—Signaling Pathways—TP53—lung cancer	4.24e-06	2.78e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—lung cancer	4.24e-06	2.77e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PIK3CA—lung cancer	4.23e-06	2.77e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CREBBP—lung cancer	4.22e-06	2.76e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCND1—lung cancer	4.22e-06	2.76e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	4.22e-06	2.76e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MTOR—lung cancer	4.22e-06	2.76e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	4.21e-06	2.76e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EP300—lung cancer	4.21e-06	2.76e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—JUN—lung cancer	4.21e-06	2.76e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—lung cancer	4.19e-06	2.74e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—lung cancer	4.17e-06	2.73e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—lung cancer	4.17e-06	2.73e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—lung cancer	4.17e-06	2.73e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SRC—lung cancer	4.16e-06	2.72e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—EP300—lung cancer	4.16e-06	2.72e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—lung cancer	4.15e-06	2.72e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCND1—lung cancer	4.15e-06	2.72e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—lung cancer	4.15e-06	2.72e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—lung cancer	4.15e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MAPK3—lung cancer	4.14e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—JUN—lung cancer	4.14e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—KRAS—lung cancer	4.14e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NRAS—lung cancer	4.14e-06	2.71e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—lung cancer	4.13e-06	2.7e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NRAS—lung cancer	4.12e-06	2.69e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTP1—lung cancer	4.11e-06	2.69e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MAPK3—lung cancer	4.1e-06	2.69e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SRC—lung cancer	4.1e-06	2.68e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—lung cancer	4.09e-06	2.68e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—HRAS—lung cancer	4.09e-06	2.68e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—lung cancer	4.09e-06	2.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—KRAS—lung cancer	4.09e-06	2.67e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—KRAS—lung cancer	4.09e-06	2.67e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—HRAS—lung cancer	4.08e-06	2.67e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CDKN1A—lung cancer	4.08e-06	2.67e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PTEN—lung cancer	4.07e-06	2.67e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCND1—lung cancer	4.06e-06	2.66e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—HRAS—lung cancer	4.06e-06	2.66e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—JUN—lung cancer	4.06e-06	2.65e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	4.05e-06	2.65e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—lung cancer	4.05e-06	2.65e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PIK3CA—lung cancer	4.03e-06	2.64e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—lung cancer	4.03e-06	2.64e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—lung cancer	4.03e-06	2.64e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	4.03e-06	2.64e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CDKN1A—lung cancer	4.01e-06	2.63e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—lung cancer	4.01e-06	2.63e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PTEN—lung cancer	4.01e-06	2.62e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NRAS—lung cancer	4e-06	2.62e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CD—lung cancer	4e-06	2.62e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CAT—lung cancer	4e-06	2.62e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—lung cancer	3.99e-06	2.61e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	3.99e-06	2.61e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOA1—lung cancer	3.98e-06	2.61e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—HRAS—lung cancer	3.97e-06	2.6e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—lung cancer	3.97e-06	2.6e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAPK3—lung cancer	3.96e-06	2.59e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—lung cancer	3.95e-06	2.59e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—lung cancer	3.95e-06	2.59e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—lung cancer	3.95e-06	2.58e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAPK3—lung cancer	3.94e-06	2.58e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—lung cancer	3.94e-06	2.58e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NRAS—lung cancer	3.94e-06	2.58e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	3.93e-06	2.57e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PTEN—lung cancer	3.92e-06	2.57e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	3.92e-06	2.56e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—lung cancer	3.91e-06	2.56e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—HRAS—lung cancer	3.91e-06	2.56e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—lung cancer	3.91e-06	2.56e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—lung cancer	3.91e-06	2.56e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—lung cancer	3.9e-06	2.56e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—lung cancer	3.9e-06	2.55e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ABCB1—lung cancer	3.89e-06	2.55e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—lung cancer	3.88e-06	2.54e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EP300—lung cancer	3.88e-06	2.54e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—lung cancer	3.88e-06	2.54e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—lung cancer	3.87e-06	2.54e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—lung cancer	3.85e-06	2.52e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—lung cancer	3.85e-06	2.52e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK3—lung cancer	3.83e-06	2.51e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—lung cancer	3.83e-06	2.51e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	3.83e-06	2.5e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—TYMS—lung cancer	3.82e-06	2.5e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EP300—lung cancer	3.82e-06	2.5e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.81e-06	2.49e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PIK3CA—lung cancer	3.8e-06	2.49e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—lung cancer	3.8e-06	2.49e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PIK3CA—lung cancer	3.79e-06	2.48e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTM1—lung cancer	3.78e-06	2.47e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCND1—lung cancer	3.78e-06	2.47e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SRC—lung cancer	3.78e-06	2.47e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	3.77e-06	2.47e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—lung cancer	3.77e-06	2.47e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—JUN—lung cancer	3.77e-06	2.47e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	3.75e-06	2.46e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PIK3CA—lung cancer	3.75e-06	2.46e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—lung cancer	3.75e-06	2.45e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—lung cancer	3.74e-06	2.45e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EP300—lung cancer	3.74e-06	2.45e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—HRAS—lung cancer	3.73e-06	2.44e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—lung cancer	3.73e-06	2.44e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—KRAS—lung cancer	3.72e-06	2.44e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SRC—lung cancer	3.71e-06	2.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—KRAS—lung cancer	3.69e-06	2.41e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—lung cancer	3.68e-06	2.41e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—lung cancer	3.68e-06	2.41e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—lung cancer	3.67e-06	2.4e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—lung cancer	3.67e-06	2.4e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	3.65e-06	2.39e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—lung cancer	3.65e-06	2.39e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PTEN—lung cancer	3.64e-06	2.39e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—lung cancer	3.64e-06	2.38e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SRC—lung cancer	3.64e-06	2.38e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CG—lung cancer	3.63e-06	2.38e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NRAS—lung cancer	3.63e-06	2.38e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—lung cancer	3.63e-06	2.38e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—lung cancer	3.63e-06	2.38e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—lung cancer	3.62e-06	2.37e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—lung cancer	3.61e-06	2.36e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—lung cancer	3.61e-06	2.36e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—lung cancer	3.59e-06	2.35e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—lung cancer	3.58e-06	2.35e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—lung cancer	3.58e-06	2.35e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP1A1—lung cancer	3.58e-06	2.34e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NRAS—lung cancer	3.57e-06	2.34e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—lung cancer	3.57e-06	2.34e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—KRAS—lung cancer	3.56e-06	2.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	3.56e-06	2.33e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ERCC2—lung cancer	3.55e-06	2.32e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	3.54e-06	2.32e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—KRAS—lung cancer	3.54e-06	2.32e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—HRAS—lung cancer	3.52e-06	2.3e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—lung cancer	3.51e-06	2.3e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—lung cancer	3.51e-06	2.3e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NRAS—lung cancer	3.5e-06	2.29e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CB—lung cancer	3.49e-06	2.28e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK3—lung cancer	3.48e-06	2.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EP300—lung cancer	3.48e-06	2.28e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—HRAS—lung cancer	3.47e-06	2.27e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—HRAS—lung cancer	3.47e-06	2.27e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—POMC—lung cancer	3.46e-06	2.26e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTGS2—lung cancer	3.46e-06	2.26e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—lung cancer	3.45e-06	2.26e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—KRAS—lung cancer	3.45e-06	2.26e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK3—lung cancer	3.42e-06	2.24e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PIK3CA—lung cancer	3.42e-06	2.24e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—KRAS—lung cancer	3.39e-06	2.22e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	3.39e-06	2.22e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—lung cancer	3.38e-06	2.21e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SRC—lung cancer	3.38e-06	2.21e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CREBBP—lung cancer	3.37e-06	2.21e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—lung cancer	3.37e-06	2.21e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	3.35e-06	2.19e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—lung cancer	3.33e-06	2.18e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—lung cancer	3.32e-06	2.18e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—lung cancer	3.32e-06	2.18e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—lung cancer	3.31e-06	2.17e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—lung cancer	3.31e-06	2.17e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—lung cancer	3.3e-06	2.16e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	3.29e-06	2.15e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—lung cancer	3.28e-06	2.15e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	3.27e-06	2.14e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—lung cancer	3.26e-06	2.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—lung cancer	3.26e-06	2.13e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—lung cancer	3.26e-06	2.13e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	3.25e-06	2.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NRAS—lung cancer	3.25e-06	2.13e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CD—lung cancer	3.19e-06	2.09e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—lung cancer	3.19e-06	2.09e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	3.17e-06	2.07e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—lung cancer	3.16e-06	2.07e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—HRAS—lung cancer	3.16e-06	2.07e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—lung cancer	3.15e-06	2.06e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—lung cancer	3.15e-06	2.06e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—HRAS—lung cancer	3.14e-06	2.05e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—KRAS—lung cancer	3.13e-06	2.05e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	3.12e-06	2.04e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	3.11e-06	2.04e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—lung cancer	3.11e-06	2.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—lung cancer	3.09e-06	2.02e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—KRAS—lung cancer	3.08e-06	2.01e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PIK3CA—lung cancer	3.07e-06	2.01e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOA1—lung cancer	3.07e-06	2.01e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—lung cancer	3.07e-06	2.01e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—lung cancer	3.07e-06	2.01e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—lung cancer	3.06e-06	2e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—lung cancer	3.03e-06	1.98e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—lung cancer	3.03e-06	1.98e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—HRAS—lung cancer	3.03e-06	1.98e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PTEN—lung cancer	3.01e-06	1.97e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—lung cancer	3.01e-06	1.97e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—KRAS—lung cancer	3.01e-06	1.97e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—HRAS—lung cancer	3.01e-06	1.97e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—lung cancer	3e-06	1.96e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—lung cancer	2.96e-06	1.94e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—HRAS—lung cancer	2.93e-06	1.92e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—lung cancer	2.9e-06	1.9e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—HRAS—lung cancer	2.88e-06	1.89e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—lung cancer	2.88e-06	1.89e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—EP300—lung cancer	2.87e-06	1.88e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CA—lung cancer	2.87e-06	1.88e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	2.83e-06	1.85e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CG—lung cancer	2.8e-06	1.84e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—lung cancer	2.8e-06	1.83e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KRAS—lung cancer	2.8e-06	1.83e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—lung cancer	2.79e-06	1.83e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CB—lung cancer	2.78e-06	1.82e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—lung cancer	2.78e-06	1.82e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—lung cancer	2.77e-06	1.81e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	2.77e-06	1.81e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTGS2—lung cancer	2.76e-06	1.81e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—lung cancer	2.76e-06	1.81e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—lung cancer	2.73e-06	1.79e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—lung cancer	2.68e-06	1.75e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—lung cancer	2.67e-06	1.75e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—POMC—lung cancer	2.67e-06	1.75e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—lung cancer	2.66e-06	1.74e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HRAS—lung cancer	2.66e-06	1.74e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—HRAS—lung cancer	2.61e-06	1.71e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CREBBP—lung cancer	2.6e-06	1.7e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—lung cancer	2.59e-06	1.69e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	2.57e-06	1.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HRAS—lung cancer	2.56e-06	1.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—lung cancer	2.54e-06	1.67e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—lung cancer	2.54e-06	1.66e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—lung cancer	2.51e-06	1.64e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—lung cancer	2.5e-06	1.64e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—lung cancer	2.49e-06	1.63e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CD—lung cancer	2.47e-06	1.61e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—lung cancer	2.45e-06	1.6e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—lung cancer	2.43e-06	1.59e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PTEN—lung cancer	2.41e-06	1.57e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HRAS—lung cancer	2.38e-06	1.56e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—lung cancer	2.35e-06	1.54e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—lung cancer	2.31e-06	1.51e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—EP300—lung cancer	2.29e-06	1.5e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—lung cancer	2.28e-06	1.49e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—lung cancer	2.26e-06	1.48e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.15e-06	1.41e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTGS2—lung cancer	2.13e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CA—lung cancer	2.13e-06	1.39e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—lung cancer	2.1e-06	1.37e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PTEN—lung cancer	1.86e-06	1.22e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—EP300—lung cancer	1.77e-06	1.16e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—lung cancer	1.74e-06	1.14e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CA—lung cancer	1.7e-06	1.11e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—lung cancer	1.39e-06	9.08e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.31e-06	8.58e-06	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—lung cancer	1.07e-06	7.01e-06	CbGpPWpGaD
